Luminex Hosts Planet xMAP Technology Symposium
News Apr 25, 2006
Luminex Corporation has announced plans for the annual Planet xMAP USA end-user technology symposium. Planet xMAP USA 2006 will be held in Dallas, Texas, May 15-17, at The Adolphus Hotel.
The Planet xMAP symposium includes presentations and workshops utilizing Luminex's xMAP® technology in clinical diagnostics and life sciences research.
Luminex will also host a similar event, Planet xMAP - Europe, October 3-4, 2006 in Amsterdam, The Netherlands.
James W. Jacobson, Ph.D., Vice President of Research & Development of Luminex Corporation, stated, "Planet xMAP is a symposium of best practices and innovative applications of our xMAP technology."
"It is a learning conference for both Luminex and our end-users with great, collaborative interaction among presenters and participants."
"We share ideas and experiences focused on multiplexing technology for better science as well as efficiency, economy and market growth."
The keynote speaker for the Planet xMAP USA Symposium is Todd R. Golub, M.D., Harvard Medical School Associate Professor of Pediatrics, who will speak on his application of xMAP technology to study the role of MicroRNA in cancer.
Planet xMAP 2006 features a dynamic program of leading industry speakers, workshops, discussion groups and networking events.
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018